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Abstract
While defaults may encourage some health behaviors, how defaults influence controversial
behaviors is not well understood. We examined the effect of two default policies on parents’
consent to have their adolescent sons hypothetically receive HPV vaccine at school. A national
sample of 404 parents of adolescent sons participated in an online 3×2 between-subjects factorial
experiment. Factors varied the default consent policy (opt-in, opt-out, or neutral) and the number
of vaccines sons would receive (HPV vaccine alone or along with two other recommended
adolescent vaccines). Among parents wanting to get their sons HPV vaccine in the next year,
consent was higher in the opt-in condition (compared to the opt-out condition) or if other
recommended adolescent vaccines would be included. Default policies had no effect among
parents undecided about HPV vaccination. Parents’ consent for school-located HPV vaccination
may be higher when presented as an opt-in decision and other vaccines are included.
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The director of the Centers for Disease Control and Prevention recently identified
interventions that make healthy options the default choice as one of the most impactful
public health actions (Frieden, 2010). Indeed, default policies, including those allowing
individuals to opt-in or opt-out of health services, have had large effects on some health
behaviors: opt-out default policies have greatly improved organ donation and influenza
vaccination among adults (Chapman et al., 2010; Johnson and Goldstein, 2003). The effect
of these policies, however, is not well understood for behaviors involved in controversy,
such as human papillomavirus (HPV) vaccination.
Starting in 2006, the Advisory Committee on Immunization Practices (ACIP) recommended
all 11–12 year-old females in the U.S. receive HPV vaccine, with catch-up vaccination for
females through age 26 (Centers for Disease Control and Prevention, 2010b; Markowitz et
al., 2007). The ACIP permissively recommended HPV vaccine for males ages 9–26 years in
2009 (Centers for Disease Control and Prevention, 2010c) and later recommended routine
vaccination for males ages 11–21 (Centers for Disease Control and Prevention, 2011a). HPV
vaccine can be administered at the same visit as other appropriate vaccines, as this likely
increases the number of adolescents receiving vaccines on schedule (Markowitz et al.,
2007). Despite recommendations, only 49% of female adolescents ages 13–17 years have
received any doses of HPV vaccine and only 32% have completed the 3-dose series (Centers
for Disease Control and Prevention, 2011b). Vaccine uptake among adolescent males is
much lower with less than 2% having received any doses (Centers for Disease Control and
Prevention, 2011b).
Countries that have implemented voluntary school-located vaccination programs have
considerably higher rates of HPV vaccine uptake, with at least 70% of adolescent females in
participating schools having received 1 or more doses (Brabin et al., 2008; Brotherton et al.,
2008; Reeve et al., 2008). Despite the U.S. having a more complex healthcare system than
these other countries and relatively few schools in the U.S. currently providing vaccines for
their students (Brener et al., 2007), voluntary school-located provision of HPV vaccine
represents a potentially effective strategy for increasing vaccine uptake among adolescents.
Similar voluntary school-located programs have increased varicella and influenza vaccine
uptake in the U.S. (Hall et al., 2000; Hull et al., 2008; Poehling et al., 2009).
Parents are critical to the success of school-located vaccination programs because they must
consent to their children receiving vaccines at school in most instances (English et al.,
2008). Since default policies may influence parents’ consent decisions, we examined the
effects of such policies on parents’ consent to their adolescent sons hypothetically receiving
HPV vaccine at school. Based on past research concerning opt-out policies (Chapman et al.,
2010; Johnson and Goldstein, 2003) and parental concerns about concomitant administration
of vaccines (Madlon-Kay and Harper, 1994; Woodin et al., 1995), we predicted consent for
HPV vaccination would be higher under an opt-out consent policy and when consent was for
only HPV vaccine. We also predicted that defaults would be especially important for parents
who were undecided about whether to get their sons HPV vaccine in the next year, as their
opinions may be more malleable than parents who already favor the vaccine.
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The HPV Immunization in Sons (HIS) Study examined parents’ attitudes and beliefs about
HPV vaccination for their sons. We surveyed parents with adolescent sons aged 11–17 years
old who were members of an existing national panel of U.S. households maintained by an
online survey company (Dennis, 2010). The national panel consists of a probability-based
sample of U.S. households, which was composed using a dual frame approach combining
list-assisted, random-digit dialing and address-based sampling.
In August and September 2010, we invited parents to participate in our online survey. We
obtained parents’ consent prior to all surveys. If a parent had more than one son aged 11–17
years, we asked the parent to think about the son with the most recent birthday when
completing their survey. Households containing one or more panel members receive a laptop
computer and free internet access in exchange for panel members completing multiple
online surveys each month. In households with existing computer and internet access, panel
members accumulate points for completing surveys that can later be redeemed for small
cash payments. The Institutional Review Board at the University of North Carolina
approved the study procedures.
Of 1195 parents invited to participate via email, 752 responded. Among parents who
responded, 73% (n=547) were eligible and completed the parent survey. Parents who
completed surveys were more likely to be male, older, non-Hispanic white, and have
household incomes of at least $60,000 than those who did not (all p<0.05), but they were
similar on all other demographic characteristics (all p>0.05). Parents with existing computer
and internet access received about 1,000 points ($1.00 equivalent) for completing our
survey. We do not report data on parents who indicated their sons had already received one
or more doses of HPV vaccine (n=11), did not respond to default policy items (n=13), or did
not want to get their sons HPV vaccine in the next year (n=119), as their responses to default
policy items would not be meaningful given the low acceptability to them of HPV vaccine
for their sons. Thus, the analytic sample included 404 parents.
Procedures
We randomly assigned parents to one of six conditions in a 3×2 between-subjects fully
crossed factorial experiment. Parents read a vignette that asked them to “Imagine that you
just moved to a new state and your son is starting at a new school. This school has a school
health center where a trained professional gives students basic health care.” Vignettes then
described a default consent policy for HPV vaccination that was: (a) opt-in (vaccination
would only occur if parents completed a form saying to); (b) opt-out (vaccination would
occur unless parents completed a form saying not to); or (c) neutral (parents completed a
form saying whether or not to vaccinate). Vignettes also described vaccine administration,
defined as the number of vaccines the son would receive: (a) HPV vaccine only; or (b) HPV
vaccine along with two other recommended adolescent vaccines (seasonal influenza and
meningococcal vaccines) (Centers for Disease Control and Prevention, 2010a).
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The HIS Study survey is available online at http://www.unc.edu/~ntbrewer/hpv.htm. The
main outcome was whether parents consented to their sons hypothetically receiving HPV
vaccine at school. Each vignette had two response options, one indicating that parents would
provide consent to vaccination and one indicating parents would not provide consent. To
provide parents with information about HPV and HPV vaccine, the survey contained several
brief informative statements prior to their vignette, including: “HPV is a common sexually
transmitted infection that sometimes leads to genital warts or cancer.”; “The HPV vaccine is
sometimes called the cervical cancer vaccine, Gardasil, or Cervarix. It was first available
only for females but is now also available for guys. By guys, we mean boys and young men
9–26 years old.”; “The HPV vaccine protects guys from getting some kinds of HPV that can
cause genital warts and some cancers.”; and “The HPV vaccine requires 3 shots over six
months.”
Participants provided information on various demographic variables (Table 1). We defined
“urban” as living in a metropolitan statistical area (MSA) and “rural” as living outside of an
MSA (Office of Management and Budget, 2000). After the survey provided parents with
information about HPV and HPV vaccine, we assessed parents’ intent to vaccinate their sons
in the next year. We present data for parents who wanted to get their sons vaccinated in the
next year or were undecided if they wanted to vaccinate their sons in the next year.
Statistical Analysis
We used chi-square tests to compare experimental conditions on demographic
characteristics. We then examined the effects of default consent policy and vaccine
administration on parents’ consent to their sons hypothetically receiving HPV vaccine at
school. We created indicator variables for the three-level default consent policy variable
prior to analyses. We stratified analyses based on parents’ intent to get their sons HPV
vaccine in the next year. We examined the main effects and interaction of the two
experimental factors using factorial logistic regression. Data were analyzed with SPSS
version 17.0 (SPSS Inc., Chicago IL), using two-tailed statistical tests and a critical alpha of
0.05.
Results
The sample included parents from all four geographic regions of the U.S. Most parents were
less than 45 years old (61%), non-Hispanic white (67%), married or living with a partner
(79%), and lived in an urban area (82%) (Table 1). About half of parents were female
(54%), had at least some college education (55%), and reported a household income of less
than $60,000 (52%). Most sons were ages 13–15 (37%) or 16–17 (35%), non-Hispanic
white (63%), had some form of health insurance (92%), and visited their regular healthcare
provider in the last year (79%). Demographic characteristics did not differ between
experimental conditions (all p>0.05).
Among parents who wanted to get their sons HPV vaccine in the next year (n=121), default
policy influenced consent (Figure 1). Parents in the opt-in condition were more likely to
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consent to their sons receiving HPV vaccine at school compared to parents in the opt-out
condition (75% vs. 52%; OR=2.72, 95% CI: 1.06–7.00, p<0.05). The neutral condition (62%
consent rate) did not differ from either the opt-in (p=0.24) or opt-out (p=0.38) conditions.
We found a similar, but attenuated, pattern among parents who were undecided about
vaccinating their sons in the next year (n=283). A slightly higher percent of parents in the
opt-in condition consented to HPV vaccination compared to the opt-out (41% vs. 34%;
p=0.34) and neutral (41% vs. 34%; p=0.27) conditions, but neither difference was
statistically significant.
Vaccine administration also affected parents’ consent for vaccination among those who
wanted to get their sons HPV vaccine in the next year (Figure 2). Parents in the condition
where sons would receive HPV vaccine along with seasonal influenza and meningococcal
vaccines consented to vaccination more frequently compared to the HPV vaccine only
condition (71% vs. 53%; OR=2.21, 95% CI: 1.03–4.74, p<0.05). Among parents who were
undecided about HPV vaccination for their sons, the number of vaccines included in the
consent form had no effect. Default consent policy and vaccine administration did not
interact among parents wanting to vaccinate in the next year (p=0.76) or those undecided
about vaccination (p=0.89).
Discussion
Among a national sample of parents with adolescent sons ages 11–17 years, we found that
default policies affected parents’ consent decisions, provided they wanted to vaccinate their
sons against HPV in the next year. Contrary to our hypothesis, these parents were more
likely to consent to HPV vaccination if it was presented as an opt-in situation, as compared
to an opt-out or neutral approach. This is in contrast to past research, where opt-in defaults
had lower rates of organ donation and influenza vaccination among adults (Chapman et al.,
2010; Johnson and Goldstein, 2003). It is worth noting that one of these studies also reported
lower consent rates for hypothetical organ donation for the opt-in condition compared to the
neutral condition (Johnson and Goldstein, 2003), which is also inconsistent with the results
of our study.
Some parents in the opt-out condition may have misinterpreted their vignettes as describing
school-mandated HPV vaccination, a controversial issue that has been met with opposition
(Haber et al., 2007; Herzog et al., 2008). To avoid such confusion, future voluntary school-
located HPV vaccination programs should clearly communicate to parents that vaccination
would not be required for school attendance. Related, parents in the opt-out condition may
have viewed the consent form as an infringement on their parental autonomy, an important
issue pertaining to adolescent immunization (Colgrove et al., 2010; Salmon and Omer,
2006). While we speculate that parental consent to school-located HPV vaccination may
therefore be higher using opt-in policies, which parents may perceive as a lesser threat to
their autonomy, additional research is needed to confirm this idea.
Parents were also more willing to consent to vaccination if HPV vaccine were to be
administered along with other recommended adolescent vaccines. These results differ from
our predictions and are somewhat surprising since many parents have expressed concerns
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about their children receiving three injections during the same healthcare visit (Madlon-Kay
and Harper, 1994; Woodin et al., 1995). Such concerns may have been outweighed by
parents recognizing the opportunity for their sons to also get seasonal influenza and
meningococcal vaccines, as many adolescents do not receive these recommended vaccines
(Centers for Disease Control and Prevention, 2010d; Centers for Disease Control and
Prevention, 2011b). Another plausible explanation is that the additional vaccines
emphasized the salutary nature of the request rather than the controversial nature of HPV
vaccine. Thus, future school-based vaccination programs may benefit by getting consent for
and providing HPV vaccine during the same visit as other recommended adolescent
vaccines. Concomitant administration of HPV vaccine with other recommended adolescent
vaccines is well-tolerated and does not interfere with the immune response elicited by the
vaccines (Reisinger et al., 2010; Vesikari et al., 2010; Wheeler et al., 2008).
Default policies had no effect among parents who were undecided about getting their sons
HPV vaccine in the next year, which was also contrary to our hypothesis. These parents may
need additional information before providing consent, regardless of default policy, to their
sons receiving HPV vaccine at school. Although our survey provided all parents with
informative statements about HPV and HPV vaccine prior to the experiment, we contacted
parents only about a year after the ACIP first issued its recommendation of HPV vaccine for
males (Centers for Disease Control and Prevention, 2010c), and awareness that males can
get HPV vaccine is low among parents (Reiter et al., 2010). Programs to increase
community awareness and knowledge levels about HPV vaccine for males are needed to
help parents currently undecided about vaccination make informed decisions. It is also
possible that some parents undecided about vaccination have strong, conflicting feelings
about HPV vaccination, and default policies may not help these parents resolve such
conflicts and consent to vaccination.
Our study examined parents’ consent for their sons to hypothetically receive HPV vaccine at
school, which may not fully reflect consent decisions parents may make in a clinical or
school setting. However, some evidence suggests that default policies affect hypothetical
and actual consent choices in a similar fashion. A past study examining the effects of default
policies on organ donation included an experiment regarding consent for hypothetical organ
donation (Johnson and Goldstein, 2003). Interestingly, the experimental results were
qualitatively similar to those observed for actual organ donation consent throughout Europe
(e.g., consent rates were lower for opt-in compared to opt-out) (Johnson and Goldstein,
2003). We suspect the gap between hypothetical and actual choices may be small for
behaviors that do not require much effort (e.g., providing consent), but widens as behaviors
require more effort from individuals (e.g., getting a colonoscopy).
Study strengths include use of a national sample of parents and an experimental design with
random assignment. Our study also had several limitations. Most participants were non-
Hispanic white and of relatively high socioeconomic status, though our sample was drawn
from an online panel similar to the U.S. population on many demographic characteristics
(Baker et al., 2003; Dennis, 2009). Parents who completed surveys differed from those who
did not on some demographic characteristics, and many parents were undecided about
vaccinating their sons in the next year. We also do not report data for parents not wanting to
Reiter et al. Page 6






















vaccinate their sons in the next year, because of their low overall acceptability of HPV
vaccine for their sons. Lastly, the generalizability of our findings to parents’ consent
decisions for their adolescent daughters, for whom guidelines also recommend routine
vaccination (Centers for Disease Control and Prevention, 2010b; Markowitz et al., 2007), to
receive HPV vaccine at school remains to be established.
Conclusions
We believe our results potentially have important public health implications. Obtaining
parents’ consent to vaccination is critical to the success of school-located vaccination
programs since such consent is required in most instances (English et al., 2008). Default
policies represent a low-cost, sustainable, and modifiable component of the consent process
that may influence parents’ consent decisions. Parents’ consent to HPV vaccination through
school-located vaccination programs may be higher with opt-in policies and when offering
HPV vaccine along with other recommended adolescent vaccines. Offering additional
vaccines may help emphasize the general benefits of adolescent vaccination rather than the
controversial nature of HPV vaccination. These strategies may be particularly effective for
parents already wanting to get their sons HPV vaccine. For parents who are undecided about
vaccination, programs are needed to increase their awareness and knowledge about HPV
vaccination for males. Additional research is needed to better understand factors affecting
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Default consent policy. Error bars indicate standard errors.
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Number of vaccines included in vaccine administration. Error bars indicate standard errors.
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